Author:
D’Angiolella Lucia Sara,Cortesi Paolo Angelo,Lafranconi Alessandra,Micale Mariangela,Mangano Sveva,Cesana Giancarlo,Mantovani Lorenzo Giovanni
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference32 articles.
1. Ogdie A, Schwartzman S, Husni ME. Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol. 2015;27(2):118–26.
2. Kerschbaumer A, Fenzl K, Erlacher L, Aletaha D. An overview of psoriatic arthritis: epidemiology, clinical features, pathophysiology and novel treatment targets. Wien Klin Wochenschr. 2016;128:791–5.
3. Haddad A, Zisman D. Comorbidities in patients with psoriatic arthritis. Rambam Maimonides Med J. 2017;8(1):e0004.
4. Zhu B, Edson-Heredia E, Gatz JL, Guo J, Shuler CL. Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study. Clin Ther. 2013;35:1376–85.
5. Cortesi PA, Scalone L, D’Angiolella L, Belisari A, Fusco F, Olivieri I, Mantovani LG. Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis. Clin Exp Rheumatol. 2012;30(4 Suppl. 33):S126–31.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献